Development of a quantitative immunofluorescent method for analysis of nuclear and cytoplasmic p53 and p21 in circulating tumor cells (CTC) as biomarkers of response to p53-targeted therapy.
Jacky Woo
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell
Weiguo Wu
Employment or Leadership Position - ApoCell
Vladislava O. Melnikova
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell
Kenna Lynn Anderes
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell
Darren W. Davis
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell